Boothbay Fund Management, LLC Veru Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.45 - $1.28 $64,065 - $182,231	142,368 Added 54.15%	405,292 $198,000
Q4 2024 Feb 14, 2025	SELL	$0.58 - $0.93 $662 - $1,062	-1,143 Reduced 0.43%	262,924 $170,000
Q1 2024 May 15, 2024	BUY	$0.37 - $0.72 $97,704 - $190,128	264,067 New	264,067 $184,000
Q3 2020 Nov 16, 2020	SELL	$2.58 - $3.36 $26,277 - $34,221	-10,185 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.01 - $4.02 $6,968 - $9,306	-2,315 Reduced 18.52%	10,185 $34,000

Q1 2020 May 15, 2020	SELL	$2.58 - $4.58 $32,149 - $57,071	-12,461 Reduced 49.92%	12,500 $41,000
Q4 2019 Feb 14, 2020	BUY	$1.86 - $3.35 $46,427 - $83,619	24,961 New	24,961 $84,000

32.7K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $204M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.